BioMarin Bucks Biotech Short Interest Trend (BIIB, BMRN, MDVN)
February 13, 2014 at 10:18 AM EST
Among the leading biotech and emerging pharmaceutical companies, Incyte (NASDAQ: INCY ) and Pharmacyclics (NASDAQ: PCYC ) saw the largest percentage declines in short interest between the January 15 and January 31 settlement dates. Short sellers shied away from Alexion Pharmaceuticals, Amgen, Biogen Idec, Dendreon, Medivation, Questcor Pharmaceuticals and